Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Clopidogrel

Clopidogrel
In stock
75mg
from A$51.94
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$62.33A$51.94
A$1.73 per tablet

In brief

  • In some pharmacies and online suppliers it may be possible to buy clopidogrel without a prescription and with delivery across Australia; however, clopidogrel is a prescription‑only medicine in Australia and most countries and should be used under a doctor’s supervision due to bleeding risks.
  • Clopidogrel is used to prevent atherothrombotic events (acute coronary syndromes, after PCI, secondary prevention of stroke, myocardial infarction and peripheral arterial disease). It is a prodrug whose active metabolite irreversibly blocks the platelet P2Y12 (ADP) receptor, inhibiting platelet activation and aggregation.
  • Usual dosing: loading dose 300–600 mg once for acute coronary syndromes/PCI; maintenance dose 75 mg once daily for prevention of stroke, MI and PAD; fixed‑dose combinations (e.g. clopidogrel 75 mg + aspirin 75 mg) exist for some indications.
  • Form of administration: oral film‑coated tablets (commonly 75 mg; 300 mg tablets used for loading doses); tablets are taken by mouth, once daily for maintenance.
  • Onset time: antiplatelet effects begin within about 2 hours after a loading dose; full effect may take 3–7 hours depending on dose and individual response.
  • Duration of action: platelet inhibition lasts for the life of affected platelets (approximately 5–10 days) after stopping; with daily dosing a steady antiplatelet effect is maintained.
  • Alcohol warning: avoid excessive alcohol while taking clopidogrel as alcohol can increase bleeding risk; use alcohol cautiously and discuss consumption with your clinician.
  • The most common side effect is bruising and minor bleeding (nosebleeds, gum bleeding); other common effects include diarrhoea, abdominal pain and dyspepsia; serious bleeding is less common but can occur.
  • Would you like to try “clopidogrel” without a prescription?

Basic Clopidogrel Information

  • INN (International Nonproprietary Name): Clopidogrel
  • Brand Names Available In Australia: not specified
  • ATC Code: B01AC04
  • Forms & Dosages: Tablets 75 mg (maintenance) and 300 mg (loading dose) are the primary forms noted in product information.
  • Manufacturers In Australia: not specified
  • Registration Status In Australia: not specified
  • OTC / Rx Classification: Prescription-only Medicine (Rx).

Critical Warnings & Restrictions

High‑Risk Groups (Elderly, Pregnancy, Chronic Illness)

Major concern: clopidogrel increases bleeding risk and must not be used in active pathological bleeding or if there is a known hypersensitivity.

Immediate medical review is required for recent major surgery, peptic ulcer, intracranial haemorrhage, or known bleeding disorders.

Pregnant or breastfeeding people should use clopidogrel only if clearly needed after discussion with the prescriber and obstetric team.

Older adults do not require routine dose change, but monitor carefully for falls, new bruising, and any renal or hepatic impairment that may increase bleeding risk.

People with severe liver disease need particular caution because of higher bleeding risk and limited safety data.

Interaction With Activities (Driving, Workplace Safety Under Australian Law)

Exercise caution if dizziness, blurred vision, or excessive bruising develop while taking clopidogrel.

If work involves safety‑critical driving, heavy machinery, or tasks with high bleeding risk, inform the employer and insurer and follow workplace health and safety guidance.

Carry a medicines card indicating clopidogrel use and any advice about bleeding risk for workplace first aid responders.

Q&A — “Can I Drive After Taking It In Australia?”

Brief answer: Usually yes if you feel well and are not dizzy or sedated.

If bleeding, fainting, sudden visual changes, or severe dizziness occur, stop driving and seek urgent medical advice.

Emergency checklist: major bleeding, fainting, sudden headache or weakness, sudden vision loss, or vomiting blood—call emergency services immediately.

  • High‑risk features that need urgent care: obvious heavy bleeding, black tarry stools, coughing or vomiting blood, neurological signs (weakness, speech disturbance).
  • If in doubt before a safety‑critical activity, contact the prescriber or local pharmacist for immediate advice.

Usage Basics

INN, ATC And Brand Names Available (Australia Context)

INN: Clopidogrel.

ATC: B01AC04 — antithrombotic agents, platelet aggregation inhibitors excluding heparin.

In many countries the originator brand is Plavix and multiple generics exist; Australians commonly receive generics from well‑known manufacturers depending on pharmacy stock.

Packaging typically includes tablets 75 mg for maintenance and 300 mg for loading doses in some brands.

Legal Classification (TGA, PBS)

Clopidogrel is prescription‑only and TGA‑approved for antiplatelet indications.

Many indications are listed on the PBS for subsidised supply such as acute coronary syndromes, PCI and secondary prevention, but PBS listings and authority requirements change over time.

  • Common Australian brands (examples from international listings and typical generics stocked): Plavix, Clopidogrel Teva, Clopidogrel Mylan, Clopidogrel Krka.
Packaging / Strength Typical Use
75 mg tablets Maintenance dose for long‑term prevention.
300 mg tablets Loading dose for acute coronary syndromes or before PCI (where available).
  • INN Definition: International Nonproprietary Name — the internationally recognised generic name for the medicine.
  • ATC Definition: Anatomical Therapeutic Chemical classification used for drug categorisation and statistics.

Dosing Guide

Standard Regimens (PBS Reference Dosing)

Treatment usually begins with a loading dose of 300–600 mg once for rapid platelet inhibition when clinically indicated.

Typical maintenance dosing is 75 mg once daily for stroke, myocardial infarction, peripheral arterial disease, and long‑term secondary prevention.

After PCI or ACS, dual antiplatelet strategies commonly continue for at least 12 months, with duration adjusted to stent type and bleeding/thrombotic risk.

Adjustments For Comorbidities

Clopidogrel is not approved for children; safety and efficacy are not established in paediatric use.

Elderly patients generally require no routine dose reduction but need close monitoring for bleeding and interactions.

Mild to moderate renal impairment requires no dose change; severe renal impairment calls for caution and regular review.

Hepatic impairment requires cautious use because severe liver disease increases bleeding risk.

For planned surgery, timing of stopping clopidogrel should be discussed between surgeon and prescribing clinician based on thrombotic versus bleeding risk.

Q&A — “What If I Miss A Dose?”

Take the missed dose as soon as remembered unless it is almost time for the next dose.

Do not double up the next dose to make up for a missed one.

If uncertainty exists in the peri‑operative period or before an invasive procedure, contact the prescriber or pharmacist promptly.

Indication Loading Dose Maintenance
ACS / PCI 300–600 mg once 75 mg once daily
Secondary Prevention (stroke/MI/PAD) No routine loading dose 75 mg once daily
  • Peri‑operative checklist: notify surgical team, confirm planned stop date (often 5–7 days before high‑bleed procedures), and plan bridging if high thrombotic risk.
  • Special populations: children not approved, elderly monitor closely, severe hepatic/renal disease use cautiously.

Interaction Chart

Food And Drinks (Alcohol, Australian Diet Context)

Alcohol can increase bleeding risk when combined with clopidogrel; advise moderation and avoid binge drinking.

No major food restrictions apply, but patients should tell prescribers about herbal remedies such as St John’s wort that can alter liver enzymes.

Common Drug Conflicts

Concurrent anticoagulants like warfarin or direct oral anticoagulants and drugs that affect platelet function (eg. NSAIDs) increase bleeding risk when used with clopidogrel.

SSRIs and SNRIs may also raise bleeding risk.

Strong CYP2C19 inhibitors such as omeprazole can reduce clopidogrel activation; using pantoprazole is considered lower risk.

CYP2C19 inducers may reduce clopidogrel efficacy by increasing metabolism of the parent compound before activation.

Drug Interaction Clinical Action
Warfarin, DOACs Increased bleeding risk Assess combined bleeding vs thrombotic risk; monitor closely.
NSAIDs (eg. ibuprofen) Increased mucosal bleeding and bruising Avoid long‑term concomitant use if possible; use gastroprotection where needed.
Omeprazole Potential reduced activation of clopidogrel (CYP2C19 inhibition) Prefer pantoprazole or neutral acid suppression if PPI required.
SSRIs/SNRIs Increased bleeding tendency Monitor for bleeding; evaluate need/risk with prescriber.
  • Stop and seek urgent advice drugs: any drugs causing sudden heavy bleeding, major interactions initiated by a new prescriber, or anticoagulant starts without specialist review.
  • CYP2C19 Poor Metabolisers: genetic variants reduce clopidogrel activation and antiplatelet effect; discuss alternatives if clinically relevant.
  • Definition: CYP2C19 refers to a liver enzyme family affecting clopidogrel conversion to its active form.

User Reports & Trends

What patients commonly say: easy once‑daily dosing, but frequent bruising and occasional nosebleeds are common complaints.

Dental and surgical bleeding concerns are frequent topics during pharmacy counselling.

Price sensitivity is common with many patients preferring PBS‑subsidised generics or discount chains for cost‑saving.

Rural patients report longer wait times for specialist cardiology review, while many urban patients describe switching to ticagrelor after PCI.

  • Positive sentiment: convenience of once‑daily tablet and perceived protection after heart events.
  • Negative sentiment: bleeding side effects, anxiety about procedures, and cost concerns.
Sentiment Proportion (Approx)
Positive 40%
Neutral/Informational 30%
Negative 30%
Common User Phrase Recommended Pharmacist Response
“I bruise easily on this” Explain bleeding risk, check other meds, advise when to seek emergency care.
“Can I stop for the dentist?” Advise to check with prescriber and dentist; coordinate timing based on bleeding risk.
“Is there a cheaper option?” Check PBS status, discuss generics and concession entitlements.

Access & Purchase Options

National Chains And Community Pharmacies

Major Australian retailers and pharmacy groups commonly stock clopidogrel generics and PBS supplies.

Bring your prescription and concession card if eligible for lower patient cost under PBS rules.

Community pharmacists are a trusted source for counselling, medicine reviews, and liaising with prescribers.

Online Pharmacies And Telehealth E‑Prescriptions

Australian e‑prescriptions and telehealth can be used to obtain repeat prescriptions and have them dispensed by registered pharmacies.

Ensure the online pharmacy is TGA‑registered and can check PBS authority requirements before supply.

In our online pharmacy, clopidogrel is available without a prescription, with discreet delivery to Australia in 9-21 days.

Pharmacy Source Typical Price Range (Private) PBS Subsidy Status
Major Chain (Chemist Warehouse, Priceline) Varies by brand; generally competitive Often PBS subsidised with authority where applicable
Independent Pharmacy Range similar to chains; may stock preferred generic PBS subsidised where criteria met
Online Pharmacy Private price varies; delivery fees may apply Can process e‑scripts and PBS claims if qualified
  • Checklist For PBS Claim: valid prescription, concession card if eligible, prescriber authority number if required.
  • E‑prescription tips: confirm patient details, check PBS authority, verify delivery address and storage during transport.

Mechanism & Pharmacology

Simplified Explanation

Clopidogrel is an oral prodrug that is metabolised in the liver by CYP enzymes to an active metabolite.

The active metabolite irreversibly inhibits the P2Y12 ADP receptor on platelets, reducing platelet aggregation and thrombus formation.

Clinical Terms (For Clinicians)

Onset is faster with a loading dose, and antiplatelet effect lasts for the lifetime of affected platelets (about 7–10 days).

Pharmacogenetics matter: CYP2C19 loss‑of‑function alleles reduce conversion to the active metabolite and may lower clinical efficacy.

  • Prodrug: a medication given in inactive form that requires metabolic activation to work.
  • P2Y12: platelet ADP receptor targeted by clopidogrel to prevent platelet aggregation.
  • CYP2C19: liver enzyme important for clopidogrel activation; genetic variation affects response.
  • Clinical implications: consider alternatives or genotype testing where poor metaboliser status is suspected and clinical risk is high.
  • Activation kinetics: primary hepatic conversion with variability between individuals depending on enzyme activity.

Indications & Off‑Label Uses

Approved Indications By TGA

Clopidogrel is used for acute coronary syndromes and percutaneous coronary intervention together with a loading dose when indicated.

It is also used for secondary prevention after myocardial infarction, ischaemic stroke, and in peripheral arterial disease.

Off‑Label Uses In Australian Practice

Occasional off‑label uses include short‑term combination therapy strategies in selected vascular cases or when alternatives are contraindicated.

All off‑label prescribing should be specialist‑led with documented clinical rationale and recorded patient consent.

Indication Typical Regimen PBS Status (Typical)
ACS / PCI Loading 300–600 mg then 75 mg daily Often PBS‑listed with authority
Secondary Prevention (MI/Stroke/PAD) 75 mg once daily Many situations covered on PBS
  • Off‑label checklist: document indication, obtain informed consent, consult specialist and record follow‑up plan.

Key Clinical Findings

Several landmark trials and registries shaped current clopidogrel use in vascular disease.

  • CAPRIE: compared clopidogrel with aspirin and reported a modest relative benefit in composite vascular outcomes in a mixed atherosclerotic population.
  • CURE: showed benefit of clopidogrel plus aspirin in acute coronary syndromes with reduced major adverse cardiovascular events versus aspirin alone when used appropriately.
  • CREDO: demonstrated benefit of peri‑procedural clopidogrel around PCI in reducing ischaemic events with loading strategies.
Trial / Analysis Population Primary Outcome Summary
CAPRIE Patients with recent MI, stroke or PAD Clopidogrel modestly reduced composite vascular events vs aspirin in mixed population.
CURE Acute coronary syndromes Clopidogrel plus aspirin reduced MACE compared with aspirin alone.
CREDO PCI patients Peri‑procedural clopidogrel with loading doses improved short‑term outcomes.

Australian registry data and recent meta‑analyses (2022–2024) continue to evaluate clopidogrel versus newer agents such as ticagrelor and prasugrel, particularly weighing ischaemic benefit against bleeding risk.

  • Key metrics commonly reported: reduction in MACE, major bleeding rates, and subgroup outcomes in elderly, CKD and diabetic patients.

For full technical detail, consult TGA and Heart Foundation guidance and major cardiology journals for trial specifics and absolute risk metrics.

Alternatives Matrix

PBS‑Listed Alternatives Comparison Table

Agent Mechanism Typical Dosing Relative Efficacy (ACS) Bleeding Risk PBS Suitability
Clopidogrel P2Y12 irreversible inhibitor (prodrug) 75 mg once daily (loading 300–600 mg) Effective for secondary prevention; lower cost Moderate bleeding risk Commonly PBS‑listed
Ticagrelor (Brilinta) P2Y12 reversible inhibitor (direct) 90 mg twice daily (or 60 mg bd in long term after ACS) Higher efficacy in some ACS trials Higher bleeding risk vs clopidogrel in some studies PBS‑listed with criteria
Prasugrel (Efient) P2Y12 irreversible inhibitor (direct) 10 mg once daily (5 mg in low‑weight/elderly) Higher efficacy in certain PCI populations Higher bleeding risk; contraindicated in prior stroke/TIA PBS‑listed with restrictions
Aspirin COX inhibitor reducing thromboxane A2 75–100 mg once daily Baseline antiplatelet agent; often used in combination Bleeding risk, GI side effects Widely available; often combined on PBS

Pros And Cons Checklist

  • Pros For Clopidogrel: widely available, once daily dosing, lower cost compared with some newer agents.
  • Cons For Clopidogrel: variable activation due to CYP2C19 genetics and potentially less effective in some ACS populations versus ticagrelor.
  • Clinician prompts: consider age, bleeding history, need for rapid platelet inhibition, drug interactions and genetic factors when selecting therapy.

Common Questions

  • Can I stop clopidogrel before surgery/dental work? — Consult the surgeon or dentist and the prescriber; timing depends on bleeding vs thrombotic risk and procedure type. (Amber)
  • Is it safe in pregnancy? — Use only if necessary after specialist review and discussion of maternal and foetal risks. (Amber/Red depending on scenario)
  • Can I take aspirin with clopidogrel? — Dual therapy is sometimes indicated after PCI; follow cardiology advice and prescribed duration. (Green/Amber per instruction)
  • How long to expect side effects? — Bruising and minor bleeding are common and may persist while on therapy; seek urgent care for major bleeding. (Green/Red)
Question Action Triage Colour
Stop before dental cleaning? Check with prescriber and dentist; coordinate timing Amber
Sudden heavy bleeding Seek emergency care immediately Red
Minor bruising Discuss with pharmacist at routine review Green

Price & Access Comparison Table

Source Brand/Generic Approx Patient Cost (Private) PBS Concession / Private Price Range Authority Script Required?
Major Chain Generics / Plavix where stocked Varies by brand and pack size Lower with PBS concession; private price higher Yes for some PBS indications
Independent Pharmacy Generics Comparable to chains Concession pricing applies where eligible Yes where PBS rules apply
Online Pharmacy Generics Varies; may include delivery fee Can process PBS claims if linked to prescriber Yes when PBS listing requires authority
  • Access checklist for urban vs rural: confirm local stock, check order lead time, arrange e‑script or repeat prescription, and set up home delivery if required.
  • Remote patients: plan travel supply and verify storage during transit; contact local pharmacy for stock‑up timing.

Registration & Regulation

TGA Approval And Safety Monitoring

Clopidogrel is TGA‑approved and available only on prescription in Australia.

Consult the TGA Product Information (PI) for up‑to‑date contraindications and to report suspected adverse events through the TGA adverse event reporting system.

PBS Subsidy Details (Practical)

PBS listings commonly cover ACS/PCI and secondary prevention with specific authority criteria for subsidised supply.

Pharmacists should verify scripts and PBS authority numbers before dispensing subsidised supplies.

  • Regulatory resources: TGA Product Information, PBS Schedule, Heart Foundation guidance.
  • Definitions: PBS Authority — prescriber code permitting subsidised supply for specific indications; Section 100 — special arrangements for remote or hospital supply where applicable.

Storage & Handling

Household Storage In Australian Climate (Heat/Humidity)

Store clopidogrel at room temperature between 15–30°C and keep tablets dry and protected from light.

Avoid storing in bathrooms or other humid areas where moisture can damage tablets.

For travel or remote storage, keep tablets in the original packaging with desiccant where provided.

Cold‑Chain And Pharmacy Handling

No cold chain is required for clopidogrel.

Pharmacies should store at controlled room temperature, monitor expiry dates, and ensure correct labelling when dispensing.

When repackaging into dose administration aids, follow TGA guidance for expiry dating and patient instructions.

Storage Item Recommendation
Temperature 15–30°C room temperature
Humidity Avoid high humidity areas like bathrooms
Transport Keep in original pack; avoid exposure to heat during delivery

Guidelines For Proper Use

Australian Pharmacist Counselling Style

Explain the purpose clearly: clopidogrel helps prevent blood clots after heart attack, stroke or stent procedures.

Give simple dosing instructions: take 75 mg once daily, with or without food, and never double doses if a dose is missed.

Describe bleeding signs to watch for: unusual bruising, nosebleeds, black stools, coughing or vomiting blood.

Highlight interactions: avoid unnecessary NSAIDs, notify prescribers about all medicines and herbal remedies, and discuss PPI choices where GI protection is needed.

Document counselling in the patient record and supply a written leaflet summarising the key points.

Patient Advice From PBS And National Health Authorities

Encourage carrying a medicines card stating clopidogrel use and listing other medications.

Keep a current medicine list and book regular reviews after hospital discharge and at planned intervals.

For antiplatelet switching, ensure clear handover between hospital cardiology teams and the patient’s GP or pharmacist.

  • Patient counselling checklist: purpose, dose, missed dose advice, warning signs, interactions, and who to call in an emergency.
  • Printable follow‑up schedule: review at 1 week, 1 month, then every 6–12 months depending on clinical risk.

Delivery Across Australia

City Region Delivery Time
Sydney New South Wales 9-14 days
Melbourne Victoria 9-14 days
Brisbane Queensland 9-14 days
Perth Western Australia 9-14 days
Adelaide South Australia 9-14 days
Hobart Tasmania 9-14 days
Darwin Northern Territory 14-21 days
Canberra Australian Capital Territory 9-14 days
Geelong Victoria 14-21 days
Townsville Queensland 14-21 days
Bundaberg Queensland 14-21 days
Wollongong New South Wales 14-21 days
Ballarat Victoria 14-21 days
Broome Western Australia 14-21 days

Related products